Se­cre­tive Chi­nese start­up be­gins first-ever clin­i­cal tri­al of cir­cu­lar RNA ther­a­py

Last month
R&D

Sarep­ta in­di­cates it's safe to con­tin­ue Ele­v­idys dos­ing in Eu­rope; Ep­silo­gen buys TigaTx

Last month
News Briefing

Re­lay Ther­a­peu­tics does third round of lay­offs in nine months, af­fect­ing about 70 em­ploy­ees

Last month
People

No­vo Nordisk ad­justs its lead­er­ship team; Dyne alums mi­grate to Cres­cent Bio­phar­ma

Last month
Peer Review

Arv­inas touts healthy vol­un­teer da­ta for Parkin­son's dis­ease PRO­TAC

Last month
R&D

Eli Lil­ly pays strug­gling Sang­amo $18M up­front to tap gene ther­a­py cap­sid

Last month
Deals
R&D

F-star man­age­ment takes com­pa­ny pri­vate, two years af­ter $161M cash ex­it to Sino's in­voX

Last month
Deals
China

Sen­ate con­firms Dr. Oz to lead Medicare agency amid HHS over­haul

Last month
People
Pharma

DOJ at­tor­ney says Boehringer In­gel­heim has 'tremen­dous lever­age' in IRA ne­go­ti­a­tions

Last month
Pharma

FDA ap­proves Am­gen's Up­liz­na in IgG4-re­lat­ed dis­ease

Last month
Pharma
FDA+

Trump has tout­ed Right to Try as a life­saver. Sev­er­al gov­ern­ment staff sup­port­ing it were just let go

Last month
FDA+

House and Sen­ate com­mit­tees call for brief­in­gs on health cuts from Kennedy

Last month
FDA+

Col­lec­tive Health is shed­ding the ‘com­peti­tor’ im­age

Last month
Health Tech

FDA will con­sol­i­date to five 'shared ser­vices of­fices,' ac­cord­ing to memo to Hill staffers

Last month
Pharma
FDA+

Roche plans Phase 3 for its lat­est Alzheimer’s drug at­tempt af­ter un­veil­ing more ear­ly da­ta

Last month
R&D

SHL Med­ical opens $220M au­toin­jec­tor site; DHL ac­quires clin­i­cal tri­al firm 

Last month
Manufacturing

PIPEs, bio­phar­ma’s fa­vorite fi­nanc­ing ve­hi­cle, freeze amid mar­ket strug­gles

Last month
Financing

Aldeyra gets an­oth­er CRL for its dry eye dis­ease drug that Ab­b­Vie has the op­tion to co-de­vel­op

Last month
Pharma
FDA+

An­oth­er TIG­IT tri­al fails as BeiGene scraps Phase 3 drug

Last month
R&D

Moon­Lake dis­clos­es up to $500M in fi­nanc­ing; OSR’s deal with in­no­va­tion fund 

Last month
News Briefing

Ex­clu­sive: Day­mark Health launch­es with $11.5M to care for can­cer pa­tients

Last month
Financing
Health Tech

No­var­tis’ Chi­nook-orig­i­nat­ed kid­ney dis­ease drug gets ac­cel­er­at­ed ap­proval

Last month
R&D

Sarep­ta, Roche pause Ele­v­idys tri­als in Eu­rope fol­low­ing pa­tient death

Last month
R&D

Ex­clu­sive: Neu­rona bags $102M to treat epilep­sy with cell ther­a­py

Last month
Financing
Startups
First page Previous page 20212223242526 Next page Last page
A service from the Financial Times